Novodiax receives two awards for Innovative ihcDirect IHC Products

Hayward, CA, February 6, 2018–  Novodiax was voted the “Best Immunoassays Development Company for 2018” and the “Most Innovative IHC Technology company” for the Company’s innovative ihcDirect Products. The award was given at the Third-Annual Biotechnology Awards by GHP (Global Health & Pharma). Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays. Novodiax’s proprietary, supersensitive enzymatic signal amplification detection system provides a revolutionary 10 minute intraoperative IHC result and accelerates Companion Diagnostic development.




For inquiries please contact: 

Novodiax, Inc.

3517 Breakwater Ave

Hayward, CA 94545, USA                                                                                                                                                                    

Toll Free: +1 (888) 439-2716

Phone: +1 (510) 342-3043

Speak Your Mind